Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 8, 2003, Pages 934-942

  Miyamoto, Yasunao ^a   Oho, Kazuhiko ^a   Kumamoto, Masafumi ^a   Toyonaga, Atsushi ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Balloon occluded retrograde transvenous obliteration; Hepatic blood flow; Intrahepatic resistance; Intrinsic clearance of indocyanine green; Spleno (gastro) renal shunt

Indexed keywords

INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; BALLOON OCCLUSION; CLINICAL ARTICLE; COLLATERAL CIRCULATION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HEPATIC VEIN; HIGH RISK PATIENT; HUMAN; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; VEIN CATHETERIZATION;

EID: 0041352324     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.03087.x     Document Type: Article

References (38)

1. Kanagawa H, Mima S, Kouyama H et al. A successfully treated case of fundic varices by retrograde transvenous obliteration with balloon. Jpn. J. Gastroenterol. 1991; 88: 1459-62 (in Japanese).
2. Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J. Gastroenterol. Hepatol. 1996; 11: 51-8.
3. Oho K, Toyonaga A, Iwao T et al. A new treatment for bleeding fundal varices with transvenous obliteration (Abstract). Gastroenterology 1996; 110: A1284.
4. Oho K, Iwao T, Sakai T et al. Randomized prospective trial for bleeding fundal varices: Endoscopic sclerotherapy vs. transvenous obliteration (Abstract). Gastroenterology 1997; 112: A1351.
5. Binomoeller KF, Brosatlo R. Variceal bleeding and portal hypertension. Endoscopy 2000; 32: 189-99.
6. Kawanaka H, Ohta M, Hashizume M et al. Portosystemic encephalopathy treated with balloon-occluded retrograde transvenous obliteration. Am. J. Gastroenterol. 1995; 90: 508-10.
7. Akahane T, Iwasaki T, Kobayashi N et al. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am. J. Gastroenterol. 1997; 92: 1026-30.
8. Hayashi S, Saeki S, Hosoi H et al. A clinical and portal hemodynamic analysis for obliteration of gastro-renal shunt communicated with gastric fundic varices. Jpn. J. Gastroenterol. 1998; 95: 755-63 (in Japanese with English abstract).
9. Keiding S. Hepatic clearance and liver blood flow. J. Hepatol. 1987; 4: 393-8.
10. Merkel C, Bolognesi M, Bellon S et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992; 102: 973-9.
11. Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K. Endoscopic classification of gastric varices. Gastrointest. Endosc. 1990; 36: 276-80.
12. Sherlock S. Hepatic coma. Gastroenterology 1968; 54: 754-7.
13. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646-9.
14. Idezuki Y. General rules for recording endoscopic findings of esophagogastric varices (1991). Japanese Society for Portal Hypertension. World J. Surg. 1995; 19: 420-3.
15. Groszmann RJ, Glickman M, Blei AT, Storer E, Conn HO. Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology 1979; 76: 253-8.
16. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin. Sci. 1961; 21: 43-57.
17. Winkler K, Bass L, Keiding S, Tygstrup N. The physiologic basis for clearance measurements in hepatology. Scand. J. Gastroenterol. 1979; 14: 439-48.
18. Navasa M, Bosch J, Reichen J et al. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patient with cirrhosis and portal hypertension. Hepatology 1988; 8: 850-4.
19. Hashizume M, Kitano S, Yamaga H, Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant (Letter). Lancet 1988; 2: 340-1.
20. Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices. A study of 230 patients with esophageal and/ or gastric varices using portal vein catheterization. Gastroenterology 1988; 95: 434-40.
21. Nakano R, Iwao T, Oho K, Toyonaga A, Tanikawa K. Splanchnic hemodynamic pattern and liver function in patients with cirrhosis and esophageal or gastric varices. Am. J. Gastroenterol. 1997; 92: 2085-9.
22. Poupon RY, Poupon RE, Lebrec D, Le Quernec L, Darnis F. Mechanisms for reduced hepatic clearance and elevated plasma levels of bile acids in cirrhosis. A study in patients with an end-to-side portacaval shunt. Gastroenterology 1981; 80: 1438-44.
23. Kim T, Shijo H, Kokawa H et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997; 25: 307-12.
24. Wood AJ, Villeneuve JP, Branch RA, Rogers LW, Shand DR. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat. Gastroenterology 1979; 76: 1358-62.
25. Kawasaki S, Imamura H, Bandai Y, Sanjo K, Idezuki Y. Direct evidence for the intact hepatocyte theory in patients with liver cirrhosis. Gastroenterology 1992; 102: 1351-5.
26. Cardoso JE, Gautreau C, Jeyaraj PR et al. Augmentation of portal blood flow improves function of human cirrhotic liver. Hepatology 1994; 19: 375-80.
27. Richter GM, Noeldge G, Palmaz JC et al. Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology 1990; 174: 1027-30.
28. Rössle M, Sellinger M, Ochs A, Haag K. Liver function and blood flow before and after TIPS (Abstract). Hepatology 1993; 18: 285A.
29. Sanyal AJ, Freedman AM, Luketic VA et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112: 889-98.
30. Ring EJ, Lake JR, Roberts JP et al. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann. Intern. Med. 1992; 116: 304-9.
31. Jalan R, Gooday R, O'Carroll RE, Redhead DN, Elton RA, Hayes PC. A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt. J. Hepatol. 1995; 23: 697-705.
32. Bar F, Battista S, Garello E et al. Short-term effects of transjugular intrahepatic portosystemic shunt (TIPS) on functional liver plasma flow in patients with advanced cirrhosis. Liver 1998; 18: 245-50.
33. Baron A, Gulberg V, Sauter G, Waggershauser T, Reiser M, Gerbes AL. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests. Hepatogastroenterology 1998; 45: 2315-21.
34. Rodriguez-Laiz JM, Banares R, Echenagusia A et al. Effects of transjugular intrahepatic portasystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension. Preliminary results. Dig. Dis. Sci. 1995; 40: 2121-7.
35. Lotterer E, Wengert A, Fleig WE. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis. Hepatology 1999; 29: 632-9.
36. Matsumoto A, Hamamoto N, Nomura T et al. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices. Am. J. Gastroenterol. 1999; 94: 643-9.
37. Jiao LR, Seifalian AM, Mathie RT, Habib N, Davidson BR. Portal flow augmentation for liver cirrhosis. Br. J. Surg. 2000; 87: 984-91.
38. Cardoso JE, Giroux L, Kassissia I, Houssin D, Habib N, Huet PM. Liver function improvement following increased portal blood flow in cirrhotic rats. Gastroenterology 1994; 107: 460-7.